Ajax-Loading

Eli Lilly and Company - Receivables Turnover

Eli Lilly and Company's Fiscal Year is From January To December.

The item "Receivables-Turnover" stands at 3.72 as of 09/30/2025.

As of the end of Eli Lilly and Company's third quarter, the item "Receivables Turnover" stands at 3.72. This represents a decrease of -1.35 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 5.70 percent compared to the value the year prior.
The 1 year change in percent is 5.70.
The 3 year change in percent is 1.48.

The Serie's long term average value is 3.59. It's latest available value, on 09/30/2025, is 3.42 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is +12.68%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -5.37%.

Receivables Turnover for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Receivables Turnover486,508,953,600.00
LogoAbbVie Inc - Receivables Turnover399,570,305,024.00
LogoRoche Holding AG - Receivables Turnover317,433,206,677.55
LogoAstraZeneca PLC - Receivables Turnover280,205,508,085.11
LogoNovartis AG - Receivables Turnover255,096,620,580.91